RTCure - Rheuma Tolerance for Cure is an EU/IMI2-funded research project aiming to develop new therapies for rheumatoid arthritis by inducing immune tolerance.
🤔If #arthritis was detected earlier, could it be prevented? The @RTCure_eu project sought to understand just that! Join us on 5 June at 11:00 for 'In conversation with RT Cure' where we'll find out about their work on #ArthritisResearch. Register here: europa.eu/!bxTW9M
ALT 🤔If #arthritis was detected earlier, could it be prevented? Join us on 5 June from 11:00 to 11:45 to find out! Register here
🔔State-of-the-Art Keynote Speaker
Meet Dr. @ProfJohnIsaacs, our State-of-the-Art keynote speaker at the 2023 Annual Scientific Meeting!
He will be delivering a keynote presentation on Precision Medicine in Rheumatoid Arthritis.
Register today🔗asm.rheum.ca
JUST PUBLISHED: Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis by G Simons, K Schölin Bywall, M Englbrecht, EC Johansson, RL Disantostefano, C Radawski @JorienVeldwijk K Raza & @DrMarieFalahee 👇
tandfonline.com/doi/full/10.…
At #BSR22 3pm you may like to attend the 'Prediction and prevention of rheumatoid arthritis: an update' session chaired by RACE's Karim Raza with talks from John Isaacs and Marie Falahee amongst others (venue Boisdale) @ProfJohnIsaacs@DrMarieFalahee@MRGNewcastle@RRG_Birmingham
JUST PUBLISHED! A systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations!
doi.org/10.1186/s13075-021-0…@ArthritisRes
What aspects of treatments to prevent RA matter most to those at risk? More studies of people's preferences are needed to guide the development of acceptable interventions! @IMI_PREFER@RRG_Birmingham @NIHRBhamBRC @BHPComms@Racegbnrdcu.be/cHyQE